Featured Clinical Trials
Learn what’s coming down the research pipeline, and find breast cancer clinical trials you may be eligible to participate in.
Researchers seek women with metastatic, HER2 positive breast cancer for a clinical trial that will test a new combination treatment.
Researchers seek women with ER positive, HER2 negative metastatic breast cancer for a clinical trial that will test letrozole in combination with a new medicine.
A clinical trial seeks 880 participants to test whether removing the tumor in the breast in newly diagnosed metastatic breast cancer helps women who receive systemic therapy to live longer than those who receive systemic therapy alone.
The new SystHERs (Systematic Therapies for HER2 positive Metastatic Breast Cancer Study) Registry seeks to enroll 1,000 people with HER2 positive metastatic breast cancer to analyze treatment patterns and outcomes.
Researchers seek 4,000 participants for a clinical trial that will study whether hormonal therapy alone is adequate treatment for early-stage invasive breast cancer that traveled to one to three axillary lymph nodes and is found to be of low or intermediate risk for recurrence by genomic tests.
A research study on immune response and suppression in different types of breast cancer seeks women diagnosed between the ages of 18 and 49 anywhere in the U.S.
Premenopausal women who are newly diagnosed with breast cancer and have not yet had chemotherapy are needed to participate in a study looking at biological factors that may relate to ovarian insufficiency after chemotherapy.
Researchers are seeking to find out if hormonal therapy with tamoxifen affects ovarian function and age of menopause onset in women with breast cancer.
Researchers seek women newly diagnosed with stage I-III breast cancer planning to undergo axillary lymph node dissection for a study on preventing and treating lymphedema.
If you are newly diagnosed, find out whether you are eligible to participate in I-SPY2, a trial measuring the effectiveness of adding new medicines to standard chemotherapy given before surgery.